Bio News
Inhibiting mitochondrial RNA polymerase (POLRMT) halts the proliferation of colorectal cancer stem cells. When POLRMT is deficient, KDM6B expression increases, blocking Wnt signaling, a key pathway in cancer growth. The findings open the possibility of a new targeted treatment for metastatic colorectal cancer, which has a 5-year survival rate of less than 15%.
Biobook Team
biobookmedia@biobook.co.krRoche’s New Drug for Uveitic Macular Edema Faces FDA Decision in July 2027
BMS Reports Concurrent Phase 3 Success in Idiopathic Pulmonary Fibrosis and Solid Tumors
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
